Chill Brands Group PLC
Chill Brands Group PLC
Your view on CHBRF
Overview
What the company does, where it operates, and who runs it.
About Chill Brands Group PLC
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Graham John William Duncan
- Headquarters
- Eastcastle House, London, GB
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Graham John William Duncan
- Headquarters
- Eastcastle House, London, GB
Chill Brands Group PLC engages in the research and development, production, and sale of cannabidiol consumer products and other lifestyle goods in the United States, the United Kingdom, and rest of Europe. The company offers tobacco alternative products, including smokes and chew pouches.
It also provides oral tinctures, soft-gel capsules, massage oils, and topical cosmetic products. The company serves its products under the Chill.com and Zoetic brands. The company was formerly known as Zoetic International Plc and changed its name to Chill Brands Group PLC in August 2021.
Chill Brands Group PLC was incorporated in 2014 and is headquartered in London, the United Kingdom.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Chill Brands Group PLC, and the rating behind it. CHBRF last traded at $0.05; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Chill Brands Group PLC. Starting points for Chill Brands Group PLC: EPS -$5.70, beta 0.80 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Chill Brands Group PLC. Chill Brands Group PLC does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Chill Brands Group PLC. Trailing twelve-month EPS for Chill Brands Group PLC stands at -$5.70. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Chill Brands Group PLC. Chill Brands Group PLC has reported as a listed company since 2015. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Chill Brands Group PLC valued side by side against its closest peers. Chill Brands Group PLC is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Chill Brands Group PLC, and how their positions are changing. At a $24.5M market value, institutional positions materially move Chill Brands Group PLC's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Chill Brands Group PLC executives and directors. Shares of Chill Brands Group PLC have traded between $0.03 and $0.05 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Chill Brands Group PLC. Chill Brands Group PLC is a $24.5M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Chill Brands Group PLC. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Chill Brands Group PLC. Coverage tracks Chill Brands Group PLC within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.